As of 2025-05-20, the EV/EBITDA ratio of Onconova Therapeutics Inc (ONTX) is 0.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ONTX's latest enterprise value is -15.08 mil USD. ONTX's TTM EBITDA according to its financial statements is -20.32 mil USD. Dividing these 2 quantities gives us the above ONTX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.4x - 7.3x | 6.9x |
| Forward P/E multiples | 5.9x - 11.8x | 7.7x |
| Fair Price | (85.30) - (99.21) | (99.21) |
| Upside | -2010.6% - -2322.2% | -2322.2% |
| Date | EV/EBITDA |